Iris Wang is Executive Director, Head of Strategy at Enfusion. In this role she drives Enfusion's growth and corporate development efforts, as well as oversees internal strategic initiatives to continuously improve our capabilities of serving clients excellently. Wang is also driving the effort to bring Enfusion’s innovative framework to investment managers in mainland China, through both establishing and implementing the complex go-to-market strategy.

Prior to joining Enfusion in 2021, Wang drove strategy, business planning and various transformational projects at Bridgewater Associates for six years, working directly with the firm’s senior management. She began her career as a consultant at Boston Consulting Group.

Wang holds a bachelor’s degree from Fudan University and an MBA from Harvard Business School.